NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Not unusual for microcap biotech companies with cutting edge cell therapy technologies that needs to be manufactured commercially for approval.

I believe they will edge it in globally through the UK, where their manufacturing is currently based and then be introduced via the ILAP program in the UK to Project Orbis. The process can be done in the UK on a more confidential basis, I believe. We shall see, but there is a lot new on that side and, as I have said before, name a cell therapy product that any major, well-regarded regulator allows to be sold for full price and manufactured domestically prior to marketing authorization.

I can’t name any. Seems a pretty special circumstance.